Clinicians to help study role of point-of-care ultrasound (POCUS) technology in patients with COVID-19
BOTHELL, Washington, February 8, 2021 / PRNewswire / – FUJIFILM Sonosite, Inc., the global leader in point-of-care ultrasound (POCUS) solutions, and the CHEST Foundation, the charitable foundation of American College of Thoracic Physicians, today announced two recipients of the CHEST Foundation research grant in ultrasound and COVID-19. Grants include $ 30,000 in support and the new launch of FUJIFILM Sonosite Sonosite PX ultrasound system for the study of Efficacy of POCUS in the diagnosis and treatment of COVID-19 patients in the intensive care unit (ICU).
From the start-February 2021, COVID-19 has killed more than 2.3 million people and infected more than 100 million people worldwide. Initial studies report that the real-time imaging, mobility and multiple uses of POCUS provide clinicians with technology that could be used for the diagnosis, treatment and follow-up care of patients with COVID-19. However, more research on the effectiveness of managing this dangerous virus is needed.
“With the number of ICU survivors with the increase in COVID-19, the management of these patients represents a research priority for the critical care community, ”said Diku Mandavia, MD, senior vice president, medical director of FUJIFILM Sonosite. “We are proud to work with the CHEST Foundation. to deepen and strengthen how POCUS can help with COVID-19 emergency care. “
FUJIFILM Sonosite and the CHEST Foundation received 16 grant applications from reputable CHEST medical professionals in United States. The ultrasound and COVID-19 research grant recipients are:
Marjan Islam, MD – Associate Professor of Medicine, Montefiore Medical Center, Bronx, New York
Dr. Islam’s study will determine the correlation between transcutaneous ultrasound (TUS) results and patient-reported dyspnea, according to the Borg Dyspnea Scale, and diagnoses such as pulmonary function tests (PFT ) and chest x-ray in patients with COVID-19. His study will also aim to assess changes in TUS outcome during admission and ICU follow-up.
Siddharth Dugar MD – Associate Staff and Director of Point-of-Care Ultrasound at Cleveland Clinic’s Respiratory Institute, Cleveland, Ohio
Dr. Dugar’s study will determine if spontaneous echo contrast is associated with reduced velocity in the venous system in critically ill COVID-19 patients, determine if the presence of spontaneous echo contrast is associated with risk increased venous thrombosis on sequential venous ultrasound and will identify whether the presence of spontaneous echo contrast is associated with altered fibrinogen and blood viscosity.
“The CHEST Foundation has a well-established history of proudly supporting research projects that aim to defend the prevention, diagnosis and treatment of lung disease. major contributor mortality associated with COVID-19. While spontaneous echo contrast (SEC) has been extensively studied in cardiology with thromboembolism and increased mortality, there remains a critical deviation in our understanding of SEC in critically ill patients with COVID-19. We look forward to seeing the results of the clinical research study conducted by these dedicated clinicians and the presentation of their findings, ”said CHEST Foundation President Ian T. Nathanson, MD, FCCP.
Clinical research studies begin on January 15, 2021 and should end from here January 15, 2022.
FUJIFILM Sonosite, Inc. is the innovator in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology. Based near Seattle, the company is represented by a global distribution network in more than 100 countries. Sonosite’s portable and compact systems extend the use of ultrasound across the clinical spectrum by bringing high-performance ultrasound to the point of patient care at a lower cost. For more information, please visit www.sonosite.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting-edge solutions to a wide range of global industries by leveraging its in-depth knowledge and foundational technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to various fields including healthcare, graphics systems, highly functional materials, optical devices, digital imaging and documentary products. These products and services are based on its broad portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2020, the company achieved an overall turnover of $ 21 billion, at an exchange rate of 109 yen to the dollar. Fujifilm is committed to responsible environmental management and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
The American College of Thoracic Physicians® (CHEST) is the world leader in the prevention, diagnosis and treatment of lung disease. Its mission is to defend advanced clinical practice, education, communication and research in pulmonary medicine. It serves as a vital link to clinical knowledge and resources for its more than 19,000 members around the world who provide patient care in pulmonary medicine, critical care and sleep medicine. For more information on the American College of Chest Physicians and its flagship journal CHEST®, visit Chestnet.org.
The CHEST Foundation, the charitable arm of the American College of Chest Physicians, advocates for lung health by supporting clinical research, community service, and patient education. Through programs supported by the CHEST Foundation, the more than 19,000 CHEST members are committed to advancing the lung health of millions of patients in local communities around the world. More … than 95 cents of every dollar raised is used to advance the foundation’s mission-oriented programming. Since its inception, the foundation has provided more than $ 10 million in funding clinical research and community service, with a reach spanning more than 60 countries. For more information on the CHEST Foundation, visit foundationpoitrine.org.
View original content to download multimedia:http://www.prnewswire.com/news-releases/fujifilm-sonosite-and-the-chest-foundation-celebrate-grant-winners-of-ultrasonography-and-covid-19-research-program-301223975.html
SOURCE FUJIFILM Sonosite, Inc.